"brand_name","med_ingredient","date_issued","manufacturer","link_id"
"Abilify","Aripiprazole","2009-11-26","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00001"
"Actemra","Tocilizumab","2010-10-04","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00002"
"Afinitor","Everolimus","2010-06-07","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00003"
"Aloxi","Palonosetron hydrochloride","2012-08-21","Eisai Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00004"
"Alrex","Loteprednol etabonate","2009-04-06","Bausch and Lomb, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00005"
"Altargo","Retapamulin","2008-11-05","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00006"
"Alvesco","Ciclesonide","2008-01-30","ALTANA Pharma Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00007"
"Apidra","Insulin glulisine","2007-07-12","sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00008"
"Aptivus","Tipranavir","2006-08-15","Boehringer Ingelheim (Canada) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00009"
"Arepanrix  H1N1 (AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine)","Haemagglutinin Strain A/California/7/2009 NYMC X-179A purified, inactivated, split-virion influenza antigen (H1N1); squalene; and DL-<span class=""fontSize140"" style=""font-family:'Times New Roman', Times, serif;"">&alpha;</span>-tocopherol.","2010-05-11","ID Biomedical doing business in Canada as GlaxoSmithKline Biologicals North America","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00010"
"Bexxar Therapy","Tositumomab; Iodine I 131 tositumomab","2006-11-08","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00020"
"Atriance","Nelarabine","2008-05-12","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00011"
"Avamys","Fluticasone furoate","2008-01-30","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00012"
"Avastin","Bevacizumab","2006-05-11","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00013"
"Azilect","Rasagiline mesylate","2008-06-22","Teva Pharmaceutical Industries Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00014"
"Banzel","Rufinamide","2011-10-12","Eisai Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00015"
"Baraclude","Entecavir","2007-01-02","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00016"
"Benlysta","Belimumab","2011-12-15","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00017"
"Berinert","C1 Esterase Inhibitor, Human","2011-01-06","CSL Behring Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00018"
"Besivance","Besifloxacin","2010-04-09","Bausch & Lomb Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00019"
"Brilinta","Ticagrelor","2011-11-29","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00021"
"Byetta","Exenatide","2011-05-27","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00022"
"Campral","Acamprosate calcium","2008-05-05","Prempharm Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00023"
"Cantrace","<sup>18</sup>F-Fluorodeoxyglucose","2008-01-28","IPET Pharmaceuticals, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00024"
"Caprelsa","Vandetanib","2012-06-19","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00025"
"Catena","Idebenone","2009-03-06","Santhera Pharmaceuticals (Switzerland) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00026"
"Cayston","Aztreonam","2010-07-29","Gilead Sciences Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00027"
"Celsentri","Maraviroc","2008-04-22","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00028"
"Cervarix","Human Papillomavirus Types 16 and 18 (Recombinant, AS04 adjuvanted)","2010-10-26","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00029"
"Edurant","Rilpivirine hydrochloride","2011-11-25","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00046"
"Champix","Varenicline tartrate","2008-01-30","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00030"
"Colesevalam hydrochloride (Lodalis)","Colesevelam hydrochloride","2012-01-27","Genzyme Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00031"
"Cimzia","Certolizumab pegol","2010-03-11","UCB Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00032"
"Civanex","Zucapsaicin","2010-11-17","Winston Laboratories, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00033"
"Cleviprex","Clevidipine","2011-07-11","The Medicines Company","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00034"
"Clolar","Clofarabine","2009-11-16","Genzyme Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00035"
"Coversyl","Perindopril arginine","2006-03-10","Servier Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00037"
"Cubicin","Daptomycin","2008-07-31","Cubist Pharmaceuticals, Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00039"
"Cymbalta","Duloxetine hydrochloride","2008-05-05","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00040"
"Daxas","Roflumilast","2011-03-08","Nycomed Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00041"
"Dexilant","Dexlansoprazole","2010-11-29","Takeda Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00042"
"Dificid","Fidaxomicin","2012-10-30","Optimer Luxembourg 2 S.à.r.l","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00043"
"Doribax","Doripenem monohydrate","2010-01-07","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00044"
"Edarbi","Azilsartan medoxomil","2012-06-26","Takeda Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00045"
"Effient","Prasugrel hydrochloride","2010-07-13","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00047"
"Efracea","Doxycycline, as doxycycline monohydrate","2012-02-28","Galderma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00048"
"Elaprase","Idursulfase","2007-12-17","Shire Human Genetic Therapies, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00049"
"Incivek","Telaprevir","2012-03-23","Vertex Pharmaceuticals (Canada) Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00070"
"Eliquis","Apixaban","2012-04-26","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00050"
"Eloxatin","Oxaliplatin","2009-02-19","sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00051"
"Emend","Aprepitant","2008-03-12","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00052"
"Emend IV","Fosaprepitant dimeglumine","2010-03-05","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00053"
"Emtriva","Emtricitabine","2006-07-05","Gilead Sciences Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00054"
"Enablex","Darifenacin hydrobromide","2006-03-31","Novartis Pharmaceuticals Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00055"
"Eraxis","Anidulafungin","2008-04-16","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00056"
"Erbitux","Cetuximab","2007-01-11","ImClone Systems Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00057"
"Exelon Patch","Rivastigmine","2008-06-22","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00058"
"Exjade","Deferasirox","2007-11-27","Novartis Pharmaceuticals Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00059"
"Fampyra","Fampridine","2012-07-09","Biogen Idec Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00060"
"Feraheme","Ferumoxytol","2012-06-26","Takeda Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00061"
"Finacea","Azelaic acid","2006-03-24","Berlex Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00062"
"Firmagon","Degarelix acetate","2010-12-16","Ferring Pharmaceuticals, Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00063"
"Flumist","Influenza Virus Type A (H1N1) <br />Influenza Virus Type A (H3N2) <br />Influenza Virus Type B","2011-01-10","AstraZeneca Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00064"
"Fosrenol","Lanthanum (as lanthanum carbonate hydrate)","2007-11-05","Shire BioChem Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00065"
"Gardasil","Recombinant human papillomavirus (Types 6, 11, 16, 18) L1 protein","2007-03-16","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00066"
"Gilenya","Fingolimod hydrochloride","2011-11-09","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00067"
"Halaven","Eribulin mesylate","2012-04-26","Eisai Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00068"
"Ilaris","Canakinumab","2010-07-19","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00069"
"Inlyta","Axitinib","2012-11-06","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00071"
"INOmax","Nitric oxide","2006-01-26","INO Therapeutics","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00072"
"Inspra","Eplerenone","2009-07-30","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00073"
"Intelence","Etravirine","2008-12-11","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00074"
"Invega","Paliperidone","2008-04-29","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00075"
"Invega","Paliperidone palmitate","2010-11-01","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00076"
"Omnitrope","Somatropin","2009-09-14","Sandoz Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00105"
"Isentress*","Raltegravir","2008-08-07","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00077"
"Ixiaro","Japanese encephalitis vaccine (inactivated, adsorbed)","2010-07-20","Intercell AG","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00078"
"Jakavi","Ruxolitinib, as ruxolitinib phosphate","2012-11-06","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00079"
"Januvia","Sitagliptin phosphate monohydrate","2008-08-19","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00080"
"Jevtana","Cabazitaxel","2011-09-07","sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00081"
"Kepivance","Palifermin","2007-02-14","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00082"
"Luveris","Lutropin alpha","2007-01-19","Serono Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00088"
"Kuvan","Sapropterin dihydrochloride","2010-08-12","BioMarin Pharmaceutical Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00083"
"Latuda","Lurasidone Hydrochloride (HCl)","2012-10-15","Sunovion Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00084"
"Leukoscan","Sulesomab","2007-01-19","Immunomedics, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00085"
"Levemir","Insulin Detemir","2006-08-09","Novo Nordisk Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00086"
"Lucentis","Ranibizumab","2007-12-21","Novartis Ophthalmics, Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00087"
"Lyrica","(S)-3-(Aminomethyl)-5-methylhexanoic acid","2007-10-30","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00089"
"Mabcampath","Alemtuzumab","2007-05-24","Genzyme Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00090"
"Macugen","Pegaptanib sodium","2006-03-01","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00091"
"Menveo","Meningococcal group A oligosaccharide conjugated to <i>Corynebacterium (C.) diphtheriae</i> CRM<sub>197</sub> protein<br />Meningococcal group C oligosaccharide conjugated to <i>C. diphtheriae</i> CRM<sub>197</sub> protein<br />Meningococcal group W-135 oligosaccharide conjugated to <i>C. diphtheriae</i> CRM<sub>197</sub> protein<br />Meningococcal group Y oligosaccharide conjugated to <i>C. diphtheriae</i> CRM<sub>197</sub> protein","2010-10-29","Novartis Vaccines and Diagnostics Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00092"
"Metvix","Methyl aminolevulinate (as methyl aminolevulinate hydrochloride)","2009-07-17","Galderma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00093"
"Natrecor","Nesiritide","2008-08-26","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00099"
"Mircera","Methoxy polyethylene glycol-epoetin beta","2009-01-19","Hoffmann-La Roche Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00094"
"Mozobil","Plerixafor","2012-04-26","Genzyme Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00095"
"Multaq","Dronedarone, as dronedarone hydrochloride","2010-01-07","sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00096"
"Mycamine","Micafungin sodium","2008-01-10","Astellas Pharma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00097"
"Myozyme","Alglucosidase alfa","2007-07-30","Genzyme Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00098"
"Vibativ","Telavancin hydrochloride","2010-01-07","Astellas Pharma Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00301"
"Nevanac Ophthalmic Suspension","Nepafenac","2008-10-29","ALCON Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00100"
"Nexavar","Sorafenib (as sorafenib tosylate)","2007-05-22","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00101"
"Nplate","Romiplostim","2009-07-21","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00102"
"Nucynta CR","Tapentadol hydrochloride","2011-04-15","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00103"
"Olmetec","Olmesartan medoxomil","2009-02-11","Schering-Plough Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00104"
"Onbrez Breezhaler","Indacaterol (as indacaterol maleate)","2012-07-11","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00106"
"Onglyza","Saxagliptin hydrochloride","2010-06-10","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00107"
"Orencia","Abatacept","2007-05-07","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00108"
"Pantoloc M","Pantoprazole magnesium","2006-06-22","ALTANA Pharma Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00109"
"Posanol","Posaconazole","2008-08-07","Schering-Plough Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00110"
"Pradax","dabigatran etexilate, as dabigatran etexilate mesilate","2008-11-06","Boehringer Ingelheim Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00111"
"Precedex","Dexmedetomidine Hydrochloride","2010-09-23","Hospira Healthcare Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00112"
"Prevnar 13","Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM<sub>197</sub> Protein)","2010-11-15","Wyeth Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00113"
"Prexige","Lumiracoxib","2007-06-27","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00114"
"Prezista","Darunavir","2007-05-22","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00115"
"Primovist","Gadoxetate disodium","2010-05-28","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00116"
"Pristiq","Desvenlafaxine succinate","2009-05-29","Wyeth Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00117"
"Raptiva","Efalizumab","2007-05-15","Serono Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00121"
"Prochymal","Remestemcel-L, <i>Ex vivo</i> Cultured Adult Human Mesenchymal Stem Cells (hMSCs)","2012-10-05","Osiris Therapeutics, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00118"
"Prolia","Denosumab","2011-01-17","Amgen Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00119"
"Rapaflo","Silodosin","2011-05-04","Watson Laboratories, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00120"
"Removab","Catumaxomab","2012-12-20","Fresenius Biotech GmbH","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00125"
"Rasilez","Aliskiren fumarate","2008-05-01","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00122"
"Recothrom","Thrombin alfa (Recombinant)","2010-08-30","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00123"
"Relistor","Methylnaltrexone bromide","2008-12-11","Wyeth Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00124"
"Resotran","Prucalopride (as prucalopride succinate)","2012-05-16","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00126"
"Revlimid","Lenalidomide","2008-06-24","Celgene","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00127"
"Revolade","Eltrombopag olamine","2011-06-14","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00128"
"Sprycel","Dasatinib (as monohydrate)","2007-08-07","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00139"
"Rotarix","Human rotavirus (strain RIX4414), live, attenuated","2008-07-23","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00129"
"RotaTeq","Rotavirus vaccine, live, oral, types G1, G2, G3, G4, and P1(8) (human/bovine reassortants)","2007-05-28","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00130"
"Ruby-Fill","Rubidium Chloride Rb 82","2012-01-23","Jubilant DraxImage Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00131"
"Samsca","Tolvaptan","2011-12-08","Otsuka Pharmaceutical Company, Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00132"
"Saphris","Asenapine, as asenapine maleate","2012-02-14","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00133"
"Sebivo","Telbivudine","2008-04-18","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00134"
"Simponi","Golimumab","2009-09-02","Centocor Ortho Biotech Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00135"
"Soliris","Eculizumab","2009-07-22","Alexion Pharmaceuticals, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00136"
"Somatuline","Lanreotide (as lanreotide acetate)","2007-03-06","Ipsen Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00137"
"Somavert","Pegvisomant","2006-11-06","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00138"
"Stelara","Ustekinumab","2009-05-27","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00140"
"Sutent","Sunitinib malate","2007-01-17","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00141"
"Swish Silver Supreme","Silver dihydrogen citrate and citric acid","2010-12-13","Charlotte Products Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00142"
"Synflorix","<ul class=""data-spacing-bottom""> <li><em>Streptococcus (S.) pneumoniae</em> polysaccharide from serotypes 1, 4, 5, 6B, 7F, 9V, 14 and 23F conjugated to Non-Typeable <em>Haemophilus influenzae</em> (NTHi) protein D (<abbr>PD</abbr>) carrier protein</li> <li><em>S. pneumoniae</em> polysaccharide from serotype 18C conjugated to tetanus toxoid (<abbr>TT</abbr>) carrier protein</li> <li><em>S. pneumoniae</em> polysaccharide from serotype 19F conjugated to diphtheria toxoid (<abbr>DT</abbr>) carrier protein</li> </ul>","2009-06-16","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00143"
"Tasigna","Nilotinib hydrochloride monohydrate","2009-05-04","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00145"
"Thelin","Sitaxsentan sodium","2007-09-18","Encysive Pharmaceuticals Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00146"
"Toctino","Alitretinoin","2010-04-12","Basilea Pharmaceuticals Corp.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00147"
"Torisel","Temsirolimus","2009-01-06","Wyeth Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00148"
"Toviaz","Fesoterodine fumarate","2012-05-30","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00149"
"Trajenta","Linagliptin","2011-12-23","Boehringer Ingelheim (Canada) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00150"
"Tramacet","Tramadol hydrochloride/acetaminophen","2008-09-17","Janssen Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00151"
"Treanda","Bendamustine hydrochloride","2012-12-10","Lundbeck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00152"
"Tretten","Catridecacog","2012-10-19","Novo Nordisk Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00153"
"Trosec","Trospium chloride","2006-07-31","Oryx Pharmaceuticals Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00154"
"Tygacil","Tigecycline","2007-03-12","Wyeth Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00155"
"Tykerb","Lapatinib ditosylate","2009-11-03","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00156"
"Tysabri","Natalizumab","2007-10-05","Biogen Idec Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00157"
"Uloric","Febuxostat","2010-12-21","Takeda Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00158"
"Elelyso","Taliglucerase alfa","2017-04-18","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00186"
"Vantas","Histrelin acetate","2006-10-27","Paladin Labs Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00159"
"Vasovist","Gadofosveset trisodium","2008-01-30","Berlex Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00160"
"Vectibix","Panitumumab","2008-12-18","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00161"
"Xiaflex","Collagenase clostridium histolyticum","2012-10-05","Auxilium Pharmaceuticals, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00162"
"Zeftera","Ceftobiprole medocaril","2009-08-14","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00163"
"Zelboraf","Vemurafenib","2012-05-30","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00164"
"Zeldox","Ziprasidone hydrochloride monohydrate","2008-06-21","Pfizer Canada Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00165"
"Zemplar","Paricalcitol","2005-11-18","Abbott Laboratories Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00166"
"Zevalin","Ibritumomab tiuxetan<br /><sup>90</sup>Y Yttrium Chlori","2006-06-23","Berlex Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00167"
"Zolinza","Vorinostat","2010-01-18","Merck Frosst Canada Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00168"
"Zytiga","Abiraterone acetate","2012-02-21","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00169"
"Adcetris","Brentuximab vedotin","2017-05-02","Seattle Genetics, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00170"
"Adempas","Riociguat","2017-06-05","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00171"
"Alprolix","Recombinant Human Coagulation Factor IX-FC Fusion Protein (rFIXFc)","2017-06-06","Biogen Idec Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00172"
"Bosulif","Bosutinib","2017-06-06","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00173"
"Breo Ellipta","Fluticasone furoate and vilanterol (as vilanterol trifenatate)","2016-06-24","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00174"
"Bystolic","Nebivolol (as Nebivolol Hydrochloride)","2016-11-22","Forest Laboratories Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00175"
"Carbaglu","Carglumic acid","2015-11-03","Orphan Europe S.A.R.L.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00176"
"Constella","Linaclotide","2015-01-06","Forest Laboratories Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00177"
"Cosentyx","Secukinumab","2017-07-13","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00178"
"Cyramza","Ramucirumab","2016-07-05","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00179"
"Daklinza","Daclatasvir (as daclatasvir dihydrochloride)","2016-10-28","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00180"
"Diacomit","Stiripentol","2013-06-04","Biocodex SA","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00181"
"Duavive","conjugated estrogens/bazedoxifene as bazedoxifene acetate","2015-11-02","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00182"
"Durezol","Difluprednate","2015-06-04","Alcon Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00183"
"Dymista","Azelastine (as azelastine hydrochloride) and fluticasone propionate","2015-06-12","Meda Pharmaceuticals Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00184"
"Egrifta","Tesamorelin acetate","2015-05-06","Theratechnologies Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00185"
"Sivextro","Tedizolid phosphate","2015-11-12","Cubist Pharmaceuticals Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00187"
"Sovaldi","Sofosbuvir","2017-04-12","Gilead Sciences Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00188"
"Stivarga","Regorafenib (as regorafenib monohydrate)","2016-11-24","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00189"
"Strensiq","Asfotase alfa","2016-12-29","Alexion Pharma International SARL","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00190"
"Stribild","Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate","2017-04-13","Gilead Sciences Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00191"
"Striverdi Respimat","Olodaterol Hydrochloride","2017-05-03","Boehringer Ingelheim (Canada) Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00192"
"Sylvant","Siltuximab","2016-07-04","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00193"
"Tafinlar","Dabrafenib (as dabrafenib mesylate)","2017-02-13","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00194"
"Tecfidera","Dimethyl fumarate","2015-12-15","Biogen Idec Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00195"
"Tivicay","Dolutegravir (as dolutegravir sodium)","2017-04-18","ViiV Healthcare ULC","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00196"
"Trintellix","Vortioxetine (as vortioxetine hydrobromide)","2015-09-21","Lundbeck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00197"
"Tudorza Genuair","Aclidinium bromide","2016-08-09","Almirall, S.A.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00198"
"Vimizim","Elosulfase alfa","2017-04-13","BioMarin International Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00199"
"Xeljanz","Tofacitinib (as tofacitinib citrate)","2017-05-15","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00200"
"Entresto","Sacubitril/valsartan (as sacubitril valsartan sodium hydrate complex)","2017-05-16","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00208"
"Xofigo","Radium Ra 223 dichloride","2017-03-23","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00201"
"Xtandi","Enzalutamide","2015-12-09","Astellas Pharma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00202"
"Zaxine","Rifaximin","2013-12-11","Salix Pharmaceuticals Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00203"
"Zonovate","Antihemophilic Factor (Recombinant, B-Domain Truncated), turoctocog alfa","2015-05-13","Novo Nordisk Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00204"
"Zydelig","Idelalisib","2016-10-25","Gilead Sciences Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00205"
"Zykadia","Ceritinib","2017-02-20","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00206"
"Blincyto","Blinatumomab","2016-10-21","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00207"
"Lenvima","Lenvatinib (as lenvatinib mesylate)","2017-05-05","Eisai Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00209"
"Eloctate","Antihemophilic Factor (Recombinant BDD), Fc Fusion Protein","2016-05-18","Biogen Idec Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00210"
"Entyvio","Vedolizumab","2017-04-03","Takeda Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00211"
"Erivedge","Vismodegib","2017-05-03","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00212"
"Esbriet","Pirfenidone","2016-08-16","InterMune International AG","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00213"
"Eylea","Aflibercept","2017-07-18","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00214"
"Ferriprox","Deferiprone","2016-09-30","ApoPharma Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00215"
"Fetzima","Levomilnacipran (as levomilnacipran hydrochloride)","2015-12-08","Actavis Specialty Pharmaceuticals Co.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00216"
"Fibristal","Ulipristal acetate","2016-06-27","Watson Laboratories Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00217"
"Firazyr","Icatibant acetate","2016-02-19","Shire Orphan Therapies Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00218"
"Victoza","Liraglutide","2010-10-26","Novo Nordisk Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00302"
"Forxiga","Dapagliflozin, as dapagliflozin propanediol monohydrate","2017-05-18","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00219"
"Fycompa","Perampanel","2016-03-10","Eisai Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00220"
"Votrient","Pazopanib hydrochloride","2010-12-07","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00309"
"Galexos","Simeprevir (as simeprevir sodium)","2016-11-01","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00221"
"Gardasil 9","Recombinant human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) L1 protein","2017-05-10","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00222"
"Vpriv","Velaglucerase alfa","2011-02-25","Shire Human Genetic Therapies, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00310"
"Gazyva","Obinutuzumab","2015-12-11","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00223"
"Juxtapid","Lomitapide mesylate","2014-09-04","Aegerion Pharmaceuticals (Canada) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00224"
"Kadcyla","Trastuzumab emtansine","2016-05-19","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00225"
"Kalydeco","Ivacaftor","2016-07-04","Vertex Pharmaceuticals (Canada) Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00226"
"Keytruda","Pembrolizumab","2016-10-19","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00227"
"Mekinist","Trametinib","2016-06-20","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00228"
"Movantik","Naloxegol (supplied as naloxegol oxalate)","2017-01-17","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00229"
"Myrbetriq","Mirabegron","2017-04-06","Astellas Pharma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00230"
"Naglazyme","Galsulfase","2016-10-25","BioMarin Pharmaceutical Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00231"
"Nesina","Alogliptin (as alogliptin benzoate)","2016-06-21","Takeda Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00232"
"Neupro","Rotigotine","2014-10-02","UCB Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00233"
"Nimenrix","Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine","2016-07-20","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00234"
"Vyvanse","Lisdexamfetamine dimesylate","2010-06-10","Shire Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00311"
"Nuwiq","Simoctocog alfa","2017-04-18","Octapharma Pharmazeutika Produktionsges.m.b.H.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00235"
"Ofev","Nintedanib","2016-01-07","Boehringer Ingelheim (Canada) Ltd. Ltee","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00236"
"Opsumit","Macitentan","2015-12-10","Actelion Pharmaceuticals Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00237"
"Otezla","Apremilast","2016-08-16","Celgene Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00238"
"Mifegymiso","Mifepristone; Misoprostol","2017-05-23","Linepharma International Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00239"
"Obizur","Antihemophilic Factor (Recombinant), Porcine Sequence","2015-12-03","Baxalta Canada Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00240"
"Plegridy","Peginterferon beta-1a","2017-05-05","Biogen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00241"
"Repatha","Evolocumab","2017-05-23","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00242"
"Saflutan","Tafluprost","2014-07-16","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00243"
"Trulicity","Dulaglutide","2016-05-04","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00244"
"Varithena","Polidocanol","2015-09-18","Provensis Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00245"
"Viibryd","Vilazodone hydrochloride","2015-09-30","Forest Laboratories Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00246"
"Zerbaxa","Ceftolozane and tazobactam","2017-05-03","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00247"
"Giotrif","Afatinib (as afatinib dimaleate)","2017-05-15","Boehringer Ingelheim (Canada) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00248"
"Harvoni","Ledipasvir, Sofosbuvir","2016-11-09","Gilead Sciences Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00249"
"Holkira Pak","12.5 mg Ombitasvir/75 mg Paritaprevir/50 mg Ritonavir","2016-10-18","AbbVie Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00250"
"Iclusig","Ponatinib, as ponatinib hydrochloride","2017-04-05","ARIAD Pharmaceuticals, Inc","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00251"
"Imbruvica","Ibrutinib","2016-02-11","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00252"
"Inflectra","Infliximab","2016-10-28","Celltrion Healthcare Co. Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00253"
"Intuniv XR","Guanfacine (as guanfacine hydrochloride)","2016-10-24","Shire Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00254"
"Invokana","Canagliflozin","2017-05-23","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00255"
"Istodax","Romidepsin","2017-05-17","Celgene Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00256"
"Jardiance","Empagliflozin","2017-05-15","Boehringer Ingelheim (Canada) Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00257"
"Jetrea","Ocriplasmin","2016-12-15","Alcon Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00258"
"Jublia","Efinaconazole","2017-07-13","Valeant Canada LP","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00259"
"Perjeta","Pertuzumab","2016-12-09","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00260"
"Pheburane","Sodium phenylbutyrate","2015-06-03","Médunik Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00261"
"Picato","Ingenol mebutate","2017-04-06","LEO Pharma Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00262"
"Pomalyst","Pomalidomide","2017-02-17","Celgene Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00263"
"Potiga","Ezogabine","2013-12-12","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00264"
"Prolensa","Bromfenac sodium sesquihydrate","2015-10-16","Bausch & Lomb Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00265"
"Revestive","Teduglutide","2015-12-08","NPS Pharma Holdings Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00267"
"Rosiver","Ivermectin","2015-07-08","Galderma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00268"
"Signifor","Pasireotide (as pasireotide diaspartate)","2015-03-25","Novartis Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00269"
"Anoro Ellipta","Umeclidinium bromide and vilanterol trifenatate","2016-06-22","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00270"
"Aptiom","Eslicarbazepine acetate","2015-12-10","Sunovion Pharmaceuticals Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00271"
"Arzerra","Ofatumumab","2012-11-02","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00273"
"Aubagio","Teriflunomide","2017-06-06","Genzyme Canada, a division of Sanofi-Aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00274"
"Bexsero","Recombinant <em>Neisseria meningitidis</em> serogroup&nbsp;B Neisseria Heparin Binding Antigen fusion protein<br />Recombinant <em>Neisseria meningitidis</em> serogroup&nbsp;B Neisserial Adhesin&nbsp;A protein<br />Recombinant <em>Neisseria meningitidis</em> serogroup&nbsp;B factor H binding protein fusion protein<br /><em>Neisseria</em> <em>meningitidis</em> serogroup&nbsp;B Outer Membrane Vesicles","2017-05-08","Novartis Vaccines and Diagnostics, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00275"
"Vesicare","Solifenacin succinate","2006-07-27","Astellas Pharma Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00300"
"Grastofil","Filgrastim","2016-10-27","Apotex Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00276"
"Praluent","Alirocumab","2017-05-16","Sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00277"
"Brivlera","Brivaracetam","2016-09-22","UCB Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00284"
"Cotellic","Cobimetinib","2016-06-27","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00278"
"Nucala","Mepolizumab","2016-06-27","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00279"
"Arepanrix H5N1","AS03-Adjuvanted H5N1 Influenza Vaccine","2016-12-29","ID Biomedical Corporation of Quebec","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00280"
"Basaglar","Insulin glargine","2016-02-23","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00281"
"Blexten","Bilastine","2017-06-05","Aralez Pharamaceuticals Trading DAC","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00282"
"Bridion","Sugammadex sodium","2016-08-03","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00283"
"Eperzan","Albiglutide","2017-01-17","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00285"
"Genvoya","elvitegravir<br />cobicistat<br />emtricitabine<br />tenofovir alafenamide (as 11.2 mg tenofovir alafenamide hemifumarate)","2017-04-19","Gilead Sciences Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00286"
"Ibrance","Palbociclib","2016-08-09","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00287"
"Idelvion","Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP)","2016-03-09","CSL Behring Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00288"
"Kyprolis","Carfilzomib","2016-06-24","Amgen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00290"
"Lynparza","Olaparib","2016-11-07","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00292"
"Opdivo","Nivolumab","2017-05-10","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00293"
"Orkambi","Lumacaftor and ivacaftor","2016-06-27","Vertex Pharmaceuticals (Canada) Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00294"
"Ravicti","Glycerol phenylbutyrate","2017-05-03","Horizon Pharma Ireland Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00296"
"Sunvepra","Asunaprevir","2016-08-08","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00297"
"Velcade","Bortezomib mannitol boronic ester","2005-12-29","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00299"
"Victrelis","Boceprevir","2011-12-22","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00303"
"Vidaza","Azacitidine","2010-06-22","Celgene","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00304"
"Vimpat","Lacosamide","2011-09-08","UCB Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00305"
"Visanne","Dienogest","2012-02-14","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00306"
"Volibris","Ambrisentan","2008-07-31","GlaxoSmithKline Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00307"
"Voltaren","Diclofenac diethylamine","2009-04-23","Novartis Consumer Health Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00308"
"Xalkori","Crizotinib","2012-07-26","Pfizer Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00312"
"Xarelto","Rivaroxaban","2009-02-13","Bayer Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00313"
"Xtoro","Finafloxacin","2016-04-13","Alcon Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00314"
"Xyrem","Sodium oxybate","2006-03-22","Orphan Medical, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00315"
"Yervoy","Ipilimumab","2012-07-06","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00316"
"Yondelis","Trabectedin","2010-09-23","Janssen-Ortho Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00317"
"Zepatier","Elbasvir and grazoprevir","2017-04-12","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00318"
"Zontivity","Vorapaxar sulfate","2016-07-18","Merck Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00319"
"Darzalex","Daratumumab","2017-05-09","Janssen Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00321"
"Praxbind","Idarucizumab","2017-05-04","Boehringer Ingelheim (Canada) Ltd","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00322"
"Empliciti","Elotuzumab","2016-08-30","Bristol-Myers Squibb Canada","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00323"
"Bepreve","Bepotastine besilate","2017-06-06","Bausch & Lomb Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00324"
"Uptravi","Selexipag","2017-04-06","Actelion Pharmaceuticals Ltd","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00326"
"Taltz","Ixekizumab","2016-10-31","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00327"
"Tagrisso","Osimertinib, as osimertinib mesylate","2016-11-02","AstraZeneca Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00328"
"Epclusa","Sofosbuvir<br />Velpatasvir","2016-11-01","Gilead Sciences Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00329"
"Remsima","Infliximab","2016-11-03","Celltrion Healthcare Co. Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00330"
"Cinqair","Reslizumab","2016-10-25","Teva Canada Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00331"
"Alecensaro","Alectinib (as alectinib hydrochloride)","2017-06-05","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00332"
"Brenzys","Etanercept","2016-11-03","Samsung Bioepis Co., Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00333"
"Ninlaro","Ixazomib (as ixazomib citrate)","2016-10-21","Takeda Canada Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00334"
"Rupatadine","Rupatadine (as rupatadine fumerate)","2016-09-29","Pediapharm Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00335"
"Afstyla","Antihemophilic Factor VIII (Recombinant), SingleChain","2017-02-17","CSL Behring Canada, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00343"
"MDK-Nitisinone","Nitisinone","2016-11-18","MendeliKABS Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00336"
"Amitiza","Lubiprostone","2015-12-24","Sucampo Pharma Americas, LLC","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00337"
"Lixiana","Edoxaban","2016-12-21","Daiichi Sankyo, Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00338"
"Venclexta","Venetoclax","2016-12-22","AbbVie Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00339"
"Adynovate","Antihemophilic Factor VIII (Recombinant), PEGylated","2016-12-30","Baxalta Canada Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00340"
"Dotarem","Gadoterate meglumine","2017-01-25","Guerbet","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00341"
"Zinbryta","Daclizumab beta","2017-02-09","Biogen Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00342"
"Orfadin","Nitisinone","2017-02-17","Swedish Orphan Biovitrum AB (publ)","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00344"
"Nitisinone Tablets","Nitisinone","2017-02-17","Cycle Pharmaceuticals Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00345"
"Viberzi","Eluxadoline","2017-03-01","Allergan Pharma Co.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00346"
"Kevzara","Sarilumab","2017-03-03","Sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00347"
"Lancora","Ivabradine hydrochloride","2017-03-06","Servier Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00348"
"Rapivab","Peramivir","2017-03-07","BioCryst Pharmaceuticals Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00349"
"Mictoryl/Mictoryl Pediatric","Propiverine hydrochloride","2017-04-03","Duchesnay Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00350"
"BAT","Botulism antitoxin heptavalent (A, B, C, D, E, F, G) - (equine)","2017-04-12","Cangene Corporation","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00351"
"NeuraCeq","Florbetaben <sup>18</sup>F","2017-04-18","IsoLogic Innovative Radiopharmaceuticals Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00352"
"Rexulti","Brexpiprazole","2017-05-12","Otsuka Pharmaceutical Co., Ltd.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00353"
"Portrazza","Necitumumab","2017-05-16","Eli Lilly Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00354"
"Brinavess","Vernakalant hydrochloride","2017-05-17","Cardiome UK Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00355"
"Tecentriq","Atezolizumab","2017-05-30","Hoffmann-La Roche Limited","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00356"
"Ocaliva","Obeticholic acid","2017-06-21","Intercept Pharmaceuticals Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00357"
"Ozanex","Ozenoxacin","2017-06-21","Ferrer Internacional, S.A.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00358"
"Cerdelga","Eliglustat","2017-07-10","Sanofi Genzyme, a division of sanofi-aventis Canada Inc.","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00359"
"Erelzi","Etanercept","2017-08-03","Sandoz Canada Incorporated","https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?lang=en&linkID=SBD00360"
